Skip to main content

Advertisement

SpringerLink
Log in

Testosterone Therapy: a Panacea for Sexual Dysfunction in Men?

  • Male Sexual Dysfunction and Disorders (AW Pastuszak and NK Gupta, Section Editors)
  • Published:
Current Sexual Health Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

In this article, we review the most recent articles examining the use of testosterone for the treatment of erectile dysfunction, reduced sexual desire, and ejaculatory dysfunction.

Recent Findings

The treatment of erectile dysfunction with testosterone therapy has long been investigated as a cure for sexual dysfunction. Men who are testosterone deficient can expect to benefit from testosterone therapy to address erectile dysfunction and libido, while ejaculatory function is unlikely to improve.

Summary

The literature supports the use of testosterone therapy in testosterone-deficient men with sexual dysfunction. We recommend advising patients about the benefits of testosterone therapy while ensuring that it will address their individual concerns, without delaying adjunct treatments for sexual dysfunction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Abbreviations

AMS:

Aging male symptom

BMSFI:

Brief Male Sexual Function Index

ED:

Erectile dysfunction

IIEF:

International Index of Erectile Function

MSHQ-EjD:

Men’s Sexual Health Questionnaire Ejaculatory Dysfunction

NO:

Nitric oxide

PDE5:

Phosphodiesterase type 5

TD:

Testosterone deficiency

TTh:

Testosterone therapy

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Zarotsky V, Huang MY, Carman W, Morgentaler A, Singhal PK, Coffin D, et al. Systematic literature review of the risk factors, comorbidities, and consequences of hypogonadism in men. Andrology. 2014;2(6):819–34. https://doi.org/10.1111/andr.274.

    Article  PubMed  CAS  Google Scholar 

  2. Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60(7):762–9. https://doi.org/10.1111/j.1742-1241.2006.00992.x.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Baltimore Longitudinal Study of A. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001;86(2):724–31. https://doi.org/10.1210/jcem.86.2.7219.

    Article  PubMed  CAS  Google Scholar 

  4. •• Araujo AB, O'Donnell AB, Brambilla DJ, Simpson WB, Longcope C, Matsumoto AM, et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2004;89(12):5920–6. https://doi.org/10.1210/jc.2003-031719. This was the first large-scale observational study to establish the relationship between testosterone deficiency and aging.

    Article  PubMed  CAS  Google Scholar 

  5. Araujo AB, Esche GR, Kupelian V, O'Donnell AB, Travison TG, Williams RE, et al. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab. 2007;92(11):4241–7. https://doi.org/10.1210/jc.2007-1245.

    Article  PubMed  CAS  Google Scholar 

  6. Moskovic DJ, Araujo AB, Lipshultz LI, Khera M. The 20-year public health impact and direct cost of testosterone deficiency in U.S. men. J Sex Med. 2013;10(2):562–9. https://doi.org/10.1111/j.1743-6109.2012.02944.x.

    Article  PubMed  Google Scholar 

  7. Traish AM, Miner MM, Morgentaler A, Zitzmann M. Testosterone deficiency. Am J Med. 2011;124(7):578–87. https://doi.org/10.1016/j.amjmed.2010.12.027.

    Article  PubMed  CAS  Google Scholar 

  8. •• Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018:jc.2018-00229-jc.2018-. doi:https://doi.org/10.1210/jc.2018-00229. This publication includes the most recent Endocrine Society guidelines for testosterone therapy.

  9. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54–61.

    Article  PubMed  CAS  Google Scholar 

  10. Isidori AM, Buvat J, Corona G, Goldstein I, Jannini EA, Lenzi A, et al. A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment-a systematic review. Eur Urol. 2014;65(1):99–112. https://doi.org/10.1016/j.eururo.2013.08.048.

    Article  PubMed  CAS  Google Scholar 

  11. Mulligan T, Schmitt B. Testosterone for erectile failure. J Gen Intern Med. 1993;8(9):517–21.

    Article  PubMed  CAS  Google Scholar 

  12. Granata AR, Rochira V, Lerchl A, Marrama P, Carani C. Relationship between sleep-related erections and testosterone levels in men. J Androl. 1997;18(5):522–7.

    PubMed  CAS  Google Scholar 

  13. Shabsigh R, Rajfer J, Aversa A, Traish AM, Yassin A, Kalinchenko SY, et al. The evolving role of testosterone in the treatment of erectile dysfunction. Int J Clin Pract. 2006;60(9):1087–92. https://doi.org/10.1111/j.1742-1241.2006.01101.x.

    Article  PubMed  CAS  Google Scholar 

  14. Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab. 2006;91(11):4335–43. https://doi.org/10.1210/jc.2006-0401.

    Article  PubMed  CAS  Google Scholar 

  15. • Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363(2):123–35. https://doi.org/10.1056/NEJMoa0911101. This is the largest cohort study evaluating symptoms most predictive of testosterone deficiency.

    Article  PubMed  CAS  Google Scholar 

  16. Karazindiyanoglu S, Cayan S. The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism. Aging Male : Off J Int Soc Stud Aging Male. 2008;11(3):146–9. https://doi.org/10.1080/13685530802290438.

    Article  CAS  Google Scholar 

  17. Okada K, Yamaguchi K, Chiba K, Miyake H, Fujisawa M. Comprehensive evaluation of androgen replacement therapy in aging Japanese men with late-onset hypogonadism. Aging Male: Off J Int Soc Stud Aging Male. 2014;17(2):72–5. https://doi.org/10.3109/13685538.2014.888052.

    Article  CAS  Google Scholar 

  18. McMahon CG, Shusterman N, Cohen B. Pharmacokinetics, clinical efficacy, safety profile, and patient-reported outcomes in patients receiving subcutaneous testosterone pellets 900 mg for treatment of symptoms associated with androgen deficiency. J Sex Med. 2017;14(7):883–90. https://doi.org/10.1016/j.jsxm.2017.04.734.

    Article  PubMed  Google Scholar 

  19. Almehmadi Y, Yassin AA, Nettleship JE, Saad F. Testosterone replacement therapy improves the health-related quality of life of men diagnosed with late-onset hypogonadism. Arab J Urol. 2016;14(1):31–6. https://doi.org/10.1016/j.aju.2015.10.002.

    Article  PubMed  Google Scholar 

  20. Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM. Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS). J Sex Med. 2011;8(11):3204–13. https://doi.org/10.1111/j.1743-6109.2011.02436.x.

    Article  PubMed  CAS  Google Scholar 

  21. Haider KS, Haider A, Doros G, Traish A. Long-term testosterone therapy improves urinary and sexual function, and quality of life in men with hypogonadism: results from a propensity matched subgroup of a controlled registry study. J Urol. 2018;199(1):257–65. https://doi.org/10.1016/j.juro.2017.07.039.

    Article  PubMed  CAS  Google Scholar 

  22. Permpongkosol S, Khupulsup K, Leelaphiwat S, Pavavattananusorn S, Thongpradit S, Petchthong T. Effects of 8-year treatment of long-acting testosterone undecanoate on metabolic parameters, urinary symptoms, bone mineral density, and sexual function in men with late-onset hypogonadism. J Sex Med. 2016;13(8):1199–211. https://doi.org/10.1016/j.jsxm.2016.06.003.

    Article  PubMed  Google Scholar 

  23. •• Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611–24. https://doi.org/10.1056/NEJMoa1506119. This is the largest long-term randomized placebo-controlled clinical trial that has been published evaluating the effect of testosterone therapy on sexual, physical and psychosocial outcomes.

  24. Cunningham GR, Stephens-Shields AJ, Rosen RC, Wang C, Bhasin S, Matsumoto AM, et al. Testosterone treatment and sexual function in older men with low testosterone levels. J Clin Endocrinol Metab. 2016;101(8):3096–104. https://doi.org/10.1210/jc.2016-1645.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. • Rosen RC, Wu F, Behre HM, Porst H, Meuleman EJH, Maggi M et al. Quality of life and sexual function benefits of long-term testosterone treatment: longitudinal results from the Registry of Hypogonadism in Men (RHYME). The journal of sexual medicine. 2017;14(9):1104–15. doi:https://doi.org/10.1016/j.jsxm.2017.07.004. This is the largest and most recent observational study investigating the effect of testosterone therapy on erectile function.

  26. • Corona G, Rastrelli G, Morgentaler A, Sforza A, Mannucci E, Maggi M. Meta-analysis of results of testosterone therapy on sexual function based on International Index of Erectile Function Scores. Eur Urol. 2017;72(6):1000–11. https://doi.org/10.1016/j.eururo.2017.03.032. This is the most recent meta-analysis of the effects of testosterone therapy on erectile function.

    Article  PubMed  CAS  Google Scholar 

  27. •• Elliott J, Kelly SE, Millar AC, Peterson J, Chen L, Johnston A, et al. Testosterone therapy in hypogonadal men: a systematic review and network meta-analysis. BMJ Open. 2017;7(11):e015284. https://doi.org/10.1136/bmjopen-2016-015284. This is the most comprehensive meta-analysis evaluating the effect of testosterone therapy on various clinical outcomes and adverse events.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Lugg J, Ng C, Rajfer J, Gonzalez-Cadavid N. Cavernosal nerve stimulation in the rat reverses castration-induced decrease in penile NOS activity. Am J Phys. 1996;271(2 Pt 1):E354–61. https://doi.org/10.1152/ajpendo.1996.271.2.E354.

    Article  CAS  Google Scholar 

  29. Giuliano F, Rampin O, Schirar A, Jardin A, Rousseau JP. Autonomic control of penile erection: modulation by testosterone in the rat. J Neuroendocrinol. 1993;5(6):677–83.

    Article  PubMed  CAS  Google Scholar 

  30. Aversa A, Isidori AM, Greco EA, Giannetta E, Gianfrilli D, Spera E, et al. Hormonal supplementation and erectile dysfunction. Eur Urol. 2004;45(5):535–8. https://doi.org/10.1016/j.eururo.2004.01.005.

    Article  PubMed  CAS  Google Scholar 

  31. • Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol. 2004;172(2):658–63. https://doi.org/10.1097/01.ju.0000132389.97804.d7. This is the first randomized clinical trial showing testosterone therapy improves response to PDE5 inhibitors in men with erectile dysfunction.

    Article  PubMed  CAS  Google Scholar 

  32. Alexander GM, Sherwin BB. The association between testosterone, sexual arousal, and selective attention for erotic stimuli in men. Horm Behav. 1991;25(3):367–81. https://doi.org/10.1016/0018-506X(91)90008-6.

    Article  PubMed  CAS  Google Scholar 

  33. Alexander GM, Swerdloff RS, Wang C, Davidson T, McDonald V, Steiner B, et al. Androgen–behavior correlations in hypogonadal men and eugonadal men. Horm Behav. 1997;31(2):110–9. https://doi.org/10.1006/hbeh.1997.1372.

    Article  PubMed  CAS  Google Scholar 

  34. Arver S, Dobs AS, Meikle AW, Allen RP, Sanders SW, Mazer NA. Improvement of sexual function in testosterone deficient men treated for 1 year with a permeation enhanced testosterone transdermal system. J Urol. 1996;155(5):1604–8. https://doi.org/10.1016/S0022-5347(01)66141-X.

    Article  PubMed  CAS  Google Scholar 

  35. Carani C, Bancroft J, Granata A, Del Rio G, Marrama P. Testosterone and erectile function, nocturnal penile tumescence and rigidity, and erectile response to visual erotic stimuli in hypogonadal and eugonadal men. Psychoneuroendocrinology. 17(6):647–54. https://doi.org/10.1016/0306-4530(92)90023-Z.

  36. King BE, Packard MG, Alexander GM. Affective properties of intra-medial preoptic area injections of testosterone in male rats. Neurosci Lett. 1999;269(3):149–52. https://doi.org/10.1016/S0304-3940(99)00440-1.

    Article  PubMed  CAS  Google Scholar 

  37. Kwan M, Greenleaf WJ, Mann J, Crapo L, Davidson JM. The nature of androgen action on male sexuality: a combined laboratory-self-report study on hypogonadal men. J Clin Endocrinol Metab. 1983;57(3):557–62. https://doi.org/10.1210/jcem-57-3-557.

    Article  PubMed  CAS  Google Scholar 

  38. Redouté J, Stoléru S, Pugeat M, Costes N, Lavenne F, Le Bars D, et al. Brain processing of visual sexual stimuli in treated and untreated hypogonadal patients. Psychoneuroendocrinology. 30(5):461–82. https://doi.org/10.1016/j.psyneuen.2004.12.003.

  39. • Brock G, Heiselman D, Maggi M, Kim SW, Rodriguez Vallejo JM, Behre HM, et al. Effect of testosterone solution 2% on testosterone concentration, sex drive and energy in hypogonadal men: results of a placebo controlled study. J Urol. 2016;195(3):699–705. https://doi.org/10.1016/j.juro.2015.10.083. This is the largest and most recent randomized placebo-controlled clinical trial investigating the effects of testosterone therapy on libido and energy level.

    Article  PubMed  CAS  Google Scholar 

  40. • Paduch DA, Polzer PK, Ni X, Basaria S. Testosterone replacement in androgen-deficient men with ejaculatory dysfunction: a randomized controlled trial. J Clin Endocrinol Metab. 2015;100(8):2956–62. https://doi.org/10.1210/jc.2014-4434. This is the only randomized placebo-controlled study evaluating the effect of testosterone therapy on ejaculatory function.

    Article  PubMed  CAS  Google Scholar 

  41. •• Mulhall JP, Trost LW, Brannigan RE, Kurtz EG, Redmon JB, Chiles KA et al. Evaluation and management of testosterone deficiency: AUA Guideline. J Urol. 2018. doi:https://doi.org/10.1016/j.juro.2018.03.115. This includes the most recent American Urological Association guidelines supporting the treatment of testosterone deficiency.

Download references

Author information

Authors and Affiliations

  1. Division of Urology, Southern Illinois University School of Medicine, PO Box 19665, Springfield, IL, 62794, USA

    Sevann Helo & Nicholas N. Tadros

  2. Southern Illinois University School of Medicine, Carbondale, IL, USA

    Peyton Thomas

Authors
  1. Sevann Helo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peyton Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nicholas N. Tadros
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicholas N. Tadros.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Male Sexual Dysfunction and Disorders

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Helo, S., Thomas, P. & Tadros, N.N. Testosterone Therapy: a Panacea for Sexual Dysfunction in Men?. Curr Sex Health Rep 10, 177–185 (2018). https://doi.org/10.1007/s11930-018-0151-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11930-018-0151-8

Keywords

Search

Navigation